SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ribi Immunochem (ribi)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mike head who wrote (81)7/3/1998 11:57:00 PM
From: needawin  Read Replies (1) of 92
 
This is the first time I've had to contemplate Ribi investment strategy. Seems Ribi has a lot going for it but needs a win (pardon the term) to make them a player. If Melacine is approved in Canada some will bail on initial pop. However, any subsequent dip may be a buying opportunity as people become more familiar with Rib's potential and impressive partners. I can't think of one reason Melacine should not be approved - it seems to offer a viable alternative to Chemo which some people can tolerate and others not as well. Lets hope this product can help people faced with such a condition.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News